104 related articles for article (PubMed ID: 9086466)
1. Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.
Hahne S; Nordstedt C; Ahlin A; Nybäck H
Neurosci Lett; 1997 Mar; 224(2):99-102. PubMed ID: 9086466
[TBL] [Abstract][Full Text] [Related]
2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
Blennow K; Hesse C; Fredman P
Neuroreport; 1994 Dec; 5(18):2534-6. PubMed ID: 7696597
[TBL] [Abstract][Full Text] [Related]
4. Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.
Zhou Z; Relkin N; Ghiso J; Smith JD; Gandy S
Mol Med; 2002 Jul; 8(7):376-81. PubMed ID: 12393935
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
Kandimalla RJ; Wani WY; Anand R; Kaushal A; Prabhakar S; Grover VK; Bharadwaj N; Jain K; Gill KD
Am J Alzheimers Dis Other Demen; 2013 May; 28(3):258-62. PubMed ID: 23612909
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
9. In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis.
Ulrich JD; Burchett JM; Restivo JL; Schuler DR; Verghese PB; Mahan TE; Landreth GE; Castellano JM; Jiang H; Cirrito JR; Holtzman DM
Mol Neurodegener; 2013 Apr; 8():13. PubMed ID: 23601557
[TBL] [Abstract][Full Text] [Related]
10. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
11. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
Neurochem Res; 2000 Apr; 25(4):511-7. PubMed ID: 10823584
[TBL] [Abstract][Full Text] [Related]
12. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease.
Pirttilä T; Koivisto K; Mehta PD; Reinikainen K; Kim KS; Kilkku O; Heinonen E; Soininen H; Riekkinen P; Wisniewski HM
Neurosci Lett; 1998 Jun; 249(1):21-4. PubMed ID: 9672379
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Talwar P; Sinha J; Grover S; Agarwal R; Kushwaha S; Srivastava MV; Kukreti R
J Neurol Sci; 2016 Jan; 360():179-87. PubMed ID: 26723997
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
[TBL] [Abstract][Full Text] [Related]
17. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
Shafaati M; Solomon A; Kivipelto M; Björkhem I; Leoni V
Neurosci Lett; 2007 Sep; 425(2):78-82. PubMed ID: 17822846
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
[TBL] [Abstract][Full Text] [Related]
19. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.
Rösler N; Wichart I; Jellinger KA
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):452-4. PubMed ID: 8774418
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein.
Lindh M; Blomberg M; Jensen M; Basun H; Lannfelt L; Engvall B; Scharnagel H; März W; Wahlund LO; Cowburn RF
Neurosci Lett; 1997 Jun; 229(2):85-8. PubMed ID: 9223597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
